[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

YU61495A - Nov farmaceutski proizvod - Google Patents

Nov farmaceutski proizvod

Info

Publication number
YU61495A
YU61495A YU61495A YU61495A YU61495A YU 61495 A YU61495 A YU 61495A YU 61495 A YU61495 A YU 61495A YU 61495 A YU61495 A YU 61495A YU 61495 A YU61495 A YU 61495A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical product
new pharmaceutical
piperidinoethoxy
unsolvated
benzo
Prior art date
Application number
YU61495A
Other languages
English (en)
Inventor
Smith Elizabeth Labell
Douglas Wayne Luke
Scott Randal Miller
Original Assignee
Eli Lilly And Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26976194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=YU61495(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/308,325 external-priority patent/US5629425A/en
Application filed by Eli Lilly And Company filed Critical Eli Lilly And Company
Publication of YU61495A publication Critical patent/YU61495A/sh
Publication of RS49513B publication Critical patent/RS49513B/sr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

NOV FARMACEUTSKI PROIZVOD - Ovaj pronalazak je usmeren na nov, nesolvatiran, kristalan oblik 6-hidroksi-2-(4-hidroksifenil)-3-/4-(2-piperidinoetoksi)benzoil/benzo/b/tiofen hidrohlorida.
YU61495A 1994-09-19 1995-09-19 Nesolvatiran kristalan 6-hidroksi-2-(4-hidroksifenil)-3-[4-(2-piperidinoetoksi)benzoil]benzo[b]tiofen hidrohlorid RS49513B (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/308,325 US5629425A (en) 1994-09-19 1994-09-19 Haloalkyl hemisolvates of 6-hydroxy-2-(4-hydroxyphenyl)-3-[4-piperidinoethoxy)-benzoyl]benzo[b]thiophene
US42791495A 1995-04-26 1995-04-26

Publications (2)

Publication Number Publication Date
YU61495A true YU61495A (sh) 1998-05-15
RS49513B RS49513B (sr) 2006-10-27

Family

ID=26976194

Country Status (51)

Country Link
US (4) US6399778B1 (sh)
JP (2) JPH08193081A (sh)
KR (2) KR100381346B1 (sh)
CN (2) CN1075069C (sh)
AP (1) AP754A (sh)
AT (2) AT502957A1 (sh)
AU (3) AU691955B2 (sh)
BE (2) BE1009626A3 (sh)
BG (1) BG62793B1 (sh)
BR (2) BR9504059A (sh)
CA (2) CA2158399C (sh)
CH (3) CH691594A5 (sh)
CO (2) CO4410191A1 (sh)
CZ (2) CZ292007B6 (sh)
DE (3) DE19549755B4 (sh)
DK (4) DK175903B1 (sh)
EE (1) EE03386B1 (sh)
EG (1) EG23763A (sh)
ES (2) ES2109882B1 (sh)
FI (2) FI112226B (sh)
FR (2) FR2732020B1 (sh)
GB (2) GB2293382B (sh)
GE (1) GEP19991821B (sh)
GR (2) GR1002709B (sh)
HK (1) HK1019009A1 (sh)
HR (2) HRP950482B1 (sh)
HU (2) HU225417B1 (sh)
IE (2) IE80883B1 (sh)
IL (3) IL115314A (sh)
IS (1) IS1788B (sh)
IT (2) IT1277602B1 (sh)
LU (2) LU88660A1 (sh)
LV (2) LV11178B (sh)
MY (1) MY116371A (sh)
NL (2) NL1001196C2 (sh)
NO (2) NO308107B1 (sh)
NZ (2) NZ280028A (sh)
OA (1) OA10406A (sh)
PE (2) PE32796A1 (sh)
PL (2) PL182450B1 (sh)
PT (2) PT101770B (sh)
RO (2) RO115259B1 (sh)
RS (2) RS49578B (sh)
SE (2) SE520721C2 (sh)
SI (2) SI9500293A (sh)
SK (1) SK283502B6 (sh)
TR (1) TR199501136A2 (sh)
TW (1) TW412534B (sh)
UA (2) UA42716C2 (sh)
UY (1) UY24040A1 (sh)
WO (1) WO1996009045A1 (sh)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
USRE38968E1 (en) 1992-07-28 2006-02-07 Eli Lilly And Company Methods for inhibiting bone loss using 6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl-4-[2-(piperidin-1-yl) ethoxyphenylimethanone hydrochloride
USRE39049E1 (en) 1992-07-28 2006-03-28 Eli Lilly And Company Methods for inhibiting bone loss
US5478847A (en) 1994-03-02 1995-12-26 Eli Lilly And Company Methods of use for inhibiting bone loss and lowering serum cholesterol
CO4410191A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
ES2341399T3 (es) * 1996-03-26 2010-06-18 Eli Lilly And Company Benziotofenos, formulaciones que contienen los mismos y procedimientos.
ZA979723B (en) 1996-10-30 1999-07-29 Lilly Co Eli Methods of preventing breast cancer.
CA2236254A1 (en) * 1997-04-30 1998-10-30 David Warren Hoard Process for preparing benzo¬b|thiophenes
CN1250563C (zh) 1999-05-04 2006-04-12 斯特拉坎有限公司 雄激素糖苷及其产生雄性征的活性
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
US6921827B2 (en) * 2000-11-27 2005-07-26 Eli Lilly And Company Process for preparing 3-aryl-benzo{b} thiophenes
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
EP1832582A1 (en) 2002-09-30 2007-09-12 A/S GEA Farmaceutisk Fabrik Novel raloxifene malonic acid addition salts and/or solvates thereof, and pharmaceutical compositions comprising these
US6861422B2 (en) 2003-02-26 2005-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositions
US20060106010A1 (en) * 2003-05-27 2006-05-18 Black Larry J Methods for inhibiting bone loss
US7501426B2 (en) 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004029784A1 (de) 2004-06-21 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue 2-Benzylaminodihydropteridinone, Verfahren zur deren Herstellung und deren Verwendung als Arzneimittel
DE102004030502A1 (de) 2004-06-24 2006-01-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Imidazole und Triazole, deren Herstellung und Verwendung als Arzneimittel
DE102004033670A1 (de) 2004-07-09 2006-02-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel
US7728134B2 (en) 2004-08-14 2010-06-01 Boehringer Ingelheim International Gmbh Hydrates and polymorphs of 4[[(7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-methoxy-N-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
US7759485B2 (en) 2004-08-14 2010-07-20 Boehringer Ingelheim International Gmbh Process for the manufacture of dihydropteridinones
US20060074088A1 (en) 2004-08-14 2006-04-06 Boehringer Ingelheim International Gmbh Dihydropteridinones for the treatment of cancer diseases
US20060058311A1 (en) 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
US20060035903A1 (en) 2004-08-14 2006-02-16 Boehringer Ingelheim International Gmbh Storage stable perfusion solution for dihydropteridinones
EP1630163A1 (de) 2004-08-25 2006-03-01 Boehringer Ingelheim Pharma GmbH & Co.KG Dihydropteridinonderivative, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
EP1797038B1 (en) 2004-09-29 2012-06-13 Bayer Pharma Aktiengesellschaft Thermodynamically stable form of bay 43-9006 tosylate
US20060068010A1 (en) * 2004-09-30 2006-03-30 Stephen Turner Method for improving the bioavailability of orally delivered therapeutics
DE102004054054A1 (de) 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102004058337A1 (de) 2004-12-02 2006-06-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung von annelierten Piperazin-2-on Derivaten
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
US7439358B2 (en) 2006-02-08 2008-10-21 Boehringer Ingelheim International Gmbh Specific salt, anhydrous and crystalline form of a dihydropteridione derivative
EP1852108A1 (en) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG DPP IV inhibitor formulations
EA015687B1 (ru) 2006-05-04 2011-10-31 Бёрингер Ингельхайм Интернациональ Гмбх Полиморфы
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
AR062927A1 (es) 2006-10-11 2008-12-17 Bayer Healthcare Ag 4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
WO2008047105A1 (en) * 2006-10-17 2008-04-24 Cipla Limited Crystalline form of benzothiophene compound and process for preparation thereof
US8258291B2 (en) * 2006-10-25 2012-09-04 Mamtek International Limited Process for the preparation of sucralose by the chlorination of sugar with triphosgene (BTC)
US20080103295A1 (en) * 2006-10-25 2008-05-01 David Losan Ho Process for the preparation of sucrose-6-ester by esterification in the presence of solid superacid catalyst
DE102007032451B4 (de) 2007-07-12 2010-09-30 Icfs Gmbh Verfahren zur Herstellung von aromatischen Ketonen
WO2009015004A1 (en) * 2007-07-20 2009-01-29 King Pharmaceuticals Research And Development, Inc. Crystals of (2-amino-4,5,6,7-tetrahydrobenzo[b]thien-3-yl)(4-chlorophenyl)methanone
WO2009019205A1 (en) 2007-08-03 2009-02-12 Boehringer Ingelheim International Gmbh Crystalline form of a dihydropteridione derivative
EP2242483B1 (en) * 2007-12-21 2013-02-20 Synthon B.V. Raloxifene composition
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US20110088613A1 (en) * 2008-06-09 2011-04-21 Massimo Ferrari Process for controlling the growth of a raloxifene hydrochloride crystal
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
RU2011113823A (ru) 2008-09-10 2012-10-20 БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE) Комбинированная терапия, предназначенная для лечения диабета и связанных с ним состояний
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh) 2008-12-23 2011-11-23 贝林格尔.英格海姆国际有限公司 有机化合物的盐形式
TW201036975A (en) 2009-01-07 2010-10-16 Boehringer Ingelheim Int Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy
WO2011000581A2 (en) 2009-07-02 2011-01-06 Synthon B.V. Raloxifene composition
EP2314581B1 (en) 2009-10-23 2012-07-25 Hexal AG A process for preparing benzo[b]thiophene derivatives
KR102668834B1 (ko) 2009-11-27 2024-05-24 베링거 인겔하임 인터내셔날 게엠베하 리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
WO2011099942A1 (en) 2010-02-09 2011-08-18 Silverstone Pharma New addition salts of raloxifene, process for the preparation thereof and use thereof in therapy
CA2797310C (en) 2010-05-05 2020-03-31 Boehringer Ingelheim International Gmbh Glp-1 receptor agonist and dpp-4 inhibitor combination therapy
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US8546566B2 (en) 2010-10-12 2013-10-01 Boehringer Ingelheim International Gmbh Process for manufacturing dihydropteridinones and intermediates thereof
IT1403083B1 (it) * 2010-10-25 2013-10-04 Fidia Farmaceutici Nuova forma polimorfa di raloxifene cloridrato
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
US9358233B2 (en) 2010-11-29 2016-06-07 Boehringer Ingelheim International Gmbh Method for treating acute myeloid leukemia
US9370535B2 (en) 2011-05-17 2016-06-21 Boehringer Ingelheim International Gmbh Method for treatment of advanced solid tumors
MX366629B (es) 2011-07-15 2019-07-17 Boehringer Ingelheim Int Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas.
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
EP2849755A1 (en) 2012-05-14 2015-03-25 Boehringer Ingelheim International GmbH A xanthine derivative as dpp -4 inhibitor for use in the treatment of podocytes related disorders and/or nephrotic syndrome
WO2013174767A1 (en) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
WO2014135834A1 (en) 2013-03-05 2014-09-12 Cipla House Oxalic acid addition salts and/or solvates of a selective estrogen receptor modulator
JP2016525532A (ja) 2013-07-26 2016-08-25 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 骨髄異形成症候群の処置
ES2950384T3 (es) 2014-02-28 2023-10-09 Boehringer Ingelheim Int Uso médico de un inhibidor de DPP-4
US9867831B2 (en) 2014-10-01 2018-01-16 Boehringer Ingelheim International Gmbh Combination treatment of acute myeloid leukemia and myelodysplastic syndrome
CN104496963A (zh) * 2014-12-02 2015-04-08 千辉药业（安徽）有限责任公司 一种盐酸雷洛昔芬的制备方法
CN109310697A (zh) 2016-06-10 2019-02-05 勃林格殷格翰国际有限公司 利格列汀和二甲双胍的组合

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869485A (en) * 1969-09-25 1975-03-04 Allied Chem Preparation of acid chlorides with phosgene in the presence of a catalyst
GB1456323A (en) * 1974-06-06 1976-11-24 Labaz Benzothiophenes process for preparing them and pharmaceutical compositions containing the same
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4358593A (en) * 1981-04-03 1982-11-09 Eli Lilly And Company Process for preparing 3-(4-aminoethoxybenzoyl)benzo[b]thiophenes
IL65378A (en) 1981-04-03 1986-02-28 Lilly Co Eli Process for preparing 3-(4-aminoethoxybenzoyl)benzo-(b)thiophenes
IL65404A0 (en) * 1981-04-03 1982-07-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
ZA822247B (en) 1981-04-03 1983-11-30 Lilly Co Eli Benzothiophene compounds and process for preparing them
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
IL65379A0 (en) 1981-04-03 1982-05-31 Lilly Co Eli Process for preparing acylated benzothiophenes
DE4117512A1 (de) * 1991-05-25 1992-11-26 Schering Ag 2-phenylbenzo(b)furane und -thiophene, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5169860A (en) 1992-03-13 1992-12-08 Eli Lilly And Company Antitumor compositions and methods of treatment
TW383306B (en) 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
EP0635264B1 (en) * 1993-06-24 1997-09-10 Eli Lilly And Company Antiestrogenic 2-phenyl-3-aroylbenzothiophenes as hypoglycemic agents
US6756388B1 (en) 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5523416A (en) 1994-07-22 1996-06-04 Eli Lilly And Company Process for preparing 3-(4-aminoethoxy-benzoyl) benzo (B)-thiophenes
CO4410191A1 (es) * 1994-09-19 1997-01-09 Lilly Co Eli SINTESIS DE 3-[4-(2-AMINOETOXI)BENZOIL]-2-ARIL-6- HIDROXIBENZO [b] TIOFENOS

Also Published As

Publication number Publication date
UA44240C2 (uk) 2002-02-15
TW412534B (en) 2000-11-21
WO1996009045A1 (en) 1996-03-28
NO953658D0 (no) 1995-09-15
LU88661A1 (fr) 1996-07-15
RO115259B1 (ro) 1999-12-30
CZ240295A3 (en) 1996-04-17
CO4410190A1 (es) 1997-01-09
DK2897A (da) 1997-01-09
IE950721A1 (en) 1996-03-20
DK175897B1 (da) 2005-05-30
IL115315A0 (en) 1995-12-31
ITMI951935A1 (it) 1997-03-15
GR1002709B (el) 1997-06-04
DE19534744A1 (de) 1996-03-21
KR960010634A (ko) 1996-04-20
LU88660A1 (fr) 1996-07-15
ITMI951935A0 (it) 1995-09-15
HK1019009A1 (en) 2000-01-14
PT101771B (pt) 1997-04-30
DK102795A (da) 1996-03-20
NL1001196A1 (nl) 1996-03-19
FI954403A (fi) 1996-03-20
US5731327A (en) 1998-03-24
ATA154295A (de) 2000-12-15
US6472531B1 (en) 2002-10-29
PT101771A (pt) 1996-04-30
ES2129293A1 (es) 1999-06-01
DK2797A (da) 1997-01-09
HUT74178A (en) 1996-11-28
FI112226B (fi) 2003-11-14
JP2860071B2 (ja) 1999-02-24
GB2293382B (en) 1998-08-19
DE19534745B4 (de) 2004-06-09
JPH08193081A (ja) 1996-07-30
SE9503213L (sv) 1996-03-20
CA2158399C (en) 2001-03-20
PL187686B1 (pl) 2004-09-30
NZ280027A (en) 1997-05-26
UA42716C2 (uk) 2001-11-15
HRP950483A2 (en) 1997-10-31
LV11177A (lv) 1996-04-20
GB2293602B (en) 1998-05-06
RS49513B (sr) 2006-10-27
DK175886B1 (da) 2005-05-23
BE1009625A3 (fr) 1997-06-03
GB9519028D0 (en) 1995-11-15
DK175903B1 (da) 2005-06-06
ITMI951936A0 (it) 1995-09-15
CH691125A5 (de) 2001-04-30
PL310517A1 (en) 1996-04-01
CZ292007B6 (cs) 2003-07-16
YU61395A (sh) 1998-09-18
NO953657L (no) 1996-03-20
SE520721C2 (sv) 2003-08-12
AU691955B2 (en) 1998-05-28
BR9504059A (pt) 1996-09-24
AU3718695A (en) 1996-04-09
HU227683B1 (en) 2011-11-28
LV11178B (en) 1996-08-20
EE03386B1 (et) 2001-04-16
LV11178A (lv) 1996-04-20
NO953657D0 (no) 1995-09-15
UY24040A1 (es) 1996-03-07
FR2724655B1 (fr) 1997-11-14
CN1132205A (zh) 1996-10-02
IL115315A (en) 1999-09-22
EG23763A (en) 2007-08-08
IL125283A (en) 2001-06-14
HU225417B1 (en) 2006-11-28
MY116371A (en) 2004-01-31
RO115260B1 (ro) 1999-12-30
CZ240395A3 (en) 1996-04-17
DK102895A (da) 1996-03-20
PE14796A1 (es) 1996-05-19
FR2724655A1 (fr) 1996-03-22
SK283502B6 (sk) 2003-08-05
FR2732020A1 (fr) 1996-09-27
PT101770A (pt) 1996-04-30
US6399778B1 (en) 2002-06-04
ES2129293B1 (es) 2000-01-16
SI9500292A (en) 1996-06-30
SE9503214D0 (sv) 1995-09-15
NL1001196C2 (nl) 1997-04-04
AU692907B2 (en) 1998-06-18
IS4446A (is) 1997-03-18
GR1002697B (el) 1997-05-22
CH691594A5 (de) 2001-08-31
CH691478A5 (de) 2001-07-31
AP9700938A0 (en) 1997-04-30
BG62793B1 (bg) 2000-08-31
NZ280028A (en) 1997-05-26
ITMI951936A1 (it) 1997-03-15
SE9503213D0 (sv) 1995-09-15
CZ290343B6 (cs) 2002-07-17
BR9504060A (pt) 1996-09-24
KR100381346B1 (ko) 2004-04-13
OA10406A (en) 2001-12-05
GB2293602A (en) 1996-04-03
TR199501136A2 (tr) 1996-06-21
ES2109882A1 (es) 1998-01-16
NL1001194A1 (nl) 1996-03-19
HUT75033A (en) 1997-03-28
LV11177B (en) 1996-08-20
IT1277601B1 (it) 1997-11-11
HRP950482B1 (en) 2007-04-30
CA2158400C (en) 2006-10-24
FI954402A (fi) 1996-03-20
IE80883B1 (en) 1999-05-19
FI121424B (fi) 2010-11-15
IT1277602B1 (it) 1997-11-11
GEP19991821B (en) 1999-11-05
DE19534745A1 (de) 1996-04-04
IE950722A1 (en) 1996-03-20
AT407988B (de) 2001-07-25
GB2293382A (en) 1996-03-27
KR960010637A (ko) 1996-04-20
IL115314A (en) 2000-02-29
HRP950483B1 (en) 2003-02-28
SE509265C2 (sv) 1998-12-21
RS49578B (sr) 2007-04-10
FI954403A0 (fi) 1995-09-18
KR100367376B1 (ko) 2003-03-06
IL115314A0 (en) 1996-05-14
DE19549755B4 (de) 2005-05-04
BG101242A (en) 1998-03-31
HRP950482A2 (en) 1998-02-28
SI9500293A (en) 1996-06-30
AP754A (en) 1999-07-22
BE1009626A3 (fr) 1997-06-03
CN1068324C (zh) 2001-07-11
US20020173645A1 (en) 2002-11-21
CA2158400A1 (en) 1996-03-20
PE32796A1 (es) 1996-08-07
FR2732020B1 (fr) 1997-11-14
IS1788B (is) 2001-11-28
ES2109882B1 (es) 1998-08-16
CN1127253A (zh) 1996-07-24
CA2158399A1 (en) 1996-03-20
NL1001194C2 (nl) 1997-04-04
JPH08176147A (ja) 1996-07-09
EE9700055A (et) 1997-08-15
CN1075069C (zh) 2001-11-21
GB9519032D0 (en) 1995-11-15
NO313996B1 (no) 2003-01-13
SK23397A3 (en) 1997-08-06
CO4410191A1 (es) 1997-01-09
HU9502721D0 (en) 1995-11-28
NO308107B1 (no) 2000-07-24
AU3173095A (en) 1996-04-04
NO953658L (no) 1996-03-20
FI954402A0 (fi) 1995-09-18
PT101770B (pt) 1997-04-30
HU9502723D0 (en) 1995-11-28
DK175887B1 (da) 2005-05-23
SE9503214L (sv) 1996-03-20
PL182450B1 (pl) 2002-01-31
AU3173195A (en) 1996-04-04
AT502957A1 (de) 2007-06-15
PL310518A1 (en) 1996-04-01

Similar Documents

Publication Publication Date Title
YU61495A (sh) Nov farmaceutski proizvod
MY112481A (en) Synthesis of 3-[4-(2-aminoethoxy)-benzoyl] -2-aryl-6-hydroxybenzo [b] thiophenes
LU91497I2 (fr) Rivaroxaban et ses sels pharmaceutiquement acceptables,hydrates,hydrates de ces sels et promédicaments
EP0765321A4 (sh)
MY131787A (en) An improved process for preparing 3-(4-aminoethoxy- benzoyl) benzo (b) - thiophenes
HU0003005D0 (en) A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl) benzo (b)thiophene hydrochloride
JO1890B1 (en) New pharmaceutical product
PT102502A (pt) Uma nova forma cristalina de hidrocloreto de 6-hidroxi-3-(4-¬2-(piperidin-1-il)etoxi|fenoxi)-2-(4-metoxifenil)benzo¬b|tiofeno
JO1894B1 (en) New pharmaceutical product
ECSP951462A (es) SINTESIS DE 3- [4--(2- AMINO-ETOXI)BENZOIL] -2- ARIL-8-HIDROXIBENZO [b] TIOFENOS (CASO X- 9295A)
ECSP951461A (es) SINTESIS DE 3- {4-(2- AMINOETOXI) BENZOIL]-2-ARIL-6- HIDROXIBENZO {b] TIOFENOS (CASO X- 9295B)
NO950716D0 (no) Nye substituerte sulfonamider
CY2344B1 (en) A novel crystalline form of 6-hydroxy-3-(4-(2-(piperidin-1-yl) ethoxy) phenoxy)-2-(4-methoxyphenyl) benzo (b) thiphene hydrochloride.
MX9606140A (es) 2-AMINO-3-AROIL-BENZO[ beta]TIOFENOS Y METODO PARA LA ELABORACION DE LOS MISMOS.
ECSP003592A (es) UNA NUEVA FORMA CRISTALINA DE CLORHIDRATO DE 6- HIDROXI- 3-(4-[2-(PIPERIDIN-1-IL) ETOXI]FENOXI)-2-(4-METOXIFENIL)BENZO [b]TIOFENO
TJ399B (en) A novel crystalline form of 6-hydroxy -3-(4-Ä2-(piperidin-1-yl) ethoxyÜ- phenoxy) -2-(4-methoxyphenyl) benzo ÄBÜ thiophene hydrochloride.